A decade ago, a program providing free medications to seniors was launched. Since then, the number of available medications has more than tripled, and the program has covered millions of patients. Prof. Ewa Marcinowska-Suchowierska, a specialist in internal medicine and geriatrics, discusses the...
Podskórna forma podawania leków anty-HER2 pozwala skrócić czas terapii z kilku godzin do zaledwie kilku minut. Dla pacjentek oznacza to większą swobodę i łatwiejsze planowanie codziennych aktywności, a dla systemu ochrony zdrowia – sprawniejszą organizację leczenia. O korzyściach tej zmiany...
Twenty-five new therapies, ten oncological and fifteen non-oncological, will bring patients the July reimbursement list. As Deputy Health Minister Katarzyna Kacperczyk said on Thursday, the announcement will be signed on Wednesday, there may still be some change on it.
On Monday, June 15, the next meeting of the Transparency Council.
After 7 years of breakthrough therapy, more than half of patients with advanced non-small cell lung cancer are alive without any tumor progression, and researchers are not yet able to determine the time limit of its effectiveness. The prognosis of patients in whom the previous standard of...
Three years ago, on June 1, 2023, the HPV vaccination program began. Poland joined more than 120 countries around the world, including virtually all European countries, that have vaccination programs aimed at children and adolescents. Previously, many local governments ran their programs - some...
CAR-T therapy is already reimbursed for the treatment of acute lymphoblastic leukemia and lymphoma. But not for myeloma. Clinicians, scientific societies and patients themselves are waiting for a reimbursement decision and are convinced that it's a matter of time and system responsibility.
On Monday, June 8, the next meeting of the Transparency Council.
The Ministry of Health has published a list of medicinal products that are not subject to financing under the Rescue Access to Drug Technology (RDTL) procedure. The Health Ministry assures that patients who started treatment before the list came into effect retain the right to continue therapy -...
Poland is aging at a rapid pace. In this context, the 65+ free drug list is not just a social benefit, but an important tool of the health care system. At the Medical Rationale of State press briefing, experts agreed: the program should be protected and expanded.
On Monday, June 1, the next meeting of the Transparency Council.
For the first time, we are above the European average in terms of the availability of innovative medicines - this would be the main news from Monday's Access GAP 2026 conference, if it were not for the fact that a huge problem has emerged: the financial crisis of the National Health Fund, which...
On Monday, May 25, the next meeting of the AOTMiT Transparency Council.
Doctors and patients speak with one voice: remission in inflammatory bowel diseases is the therapeutic goal today, and modern drugs are changing the lives of patients - but only those who reach them. And this is still a problem in Poland.
April's reimbursement list brought long-awaited changes for lung cancer patients. Among the new therapies was amivantamab, a novel bispecific antibody reimbursed in two indications for patients with EGFR mutations.
Nusinersen was the first drug used to treat spinal muscular atrophy in Poland, and after seven years of clinical experience it remains a therapy with proven efficacy and safety. - In the majority of patients, we observe not only stabilization of the disease, but also real improvement in...
On Monday, May 18, the next meeting of the Transparency Council.
The introduction of nusinersen has completely changed the prognosis of patients with spinal muscular atrophy, emphasizes Prof. Magdalena Chrościńska-Krawczyk, head of the Department of Pediatric Neurology at the University Children's Hospital in Lublin. Thanks to the therapy, children with the...
The Polish Society of Rheumatology reports that access to innovative treatment for patients with rheumatic diseases in Poland is steadily improving. Due to the complex pathomechanism, heterogeneous clinical picture, co-occurrence of other diseases and individual variation in response to...
Motoneurons are responsible for muscle movement and strength, and their loss is a key problem in SMA. Prof. Anna Kostera-Pruszczyk, head of the Department of Neurology at Warsaw Medical University's UCK WUM Central Clinical Hospital, stresses that modern treatment makes it possible not only to...
On Monday, May 11, the next meeting of the AOTMiT Transparency Council.
On Monday, May 4, the next meeting of the Transparency Council.
His health problems began eight years ago, at the age of 31. However, he never thought it could be something serious. It started with progressive fatigue, weakness, and joint and bone pain. Since he was training extensively in table tennis at the time, he associated these symptoms with training...
- When I first heard about this therapy, I thought we were talking about a trip to Mars. And I absolutely did not even dream that it would be available in our country," recalls Prof. Lidia Gil. Polish patients with plasmocytic myeloma are waiting for access to this therapy.
- Migraine is not just a headache - it's really a lot of suffering that affects the entire brain. It's hypersensitivity to stimuli, difficulty adapting to new and difficult factors, and severe attacks of pain accompanied by nausea, vomiting and hypersensitivity to light, sounds or smells. These...
Peter was born with fish scales and the accompanying Atopic Dermatitis. Today he is eight years old and battles chronic skin disease, itching and flaky skin every day. These symptoms not only affect his comfort, but also his sleep and mood. Proper care and specialized therapeutic clothing play a...
On Monday, April 13, the next meeting of the AOTMiT Transparency Council.
Jaki był powód decyzji?
W poniedziałek 9 marca kolejne posiedzenie Rady Przejrzystości AOTMiT.
© 2023 Medexpress. All Rights Reserved
